PANAGORA ASSET MANAGEMENT INC
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 883677
Boston, MA
Position in XERS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,802,425
+$1,194,910 QoQ
Shares Held
227,579
+117.3% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#6
of 64 holders
Holding Since
Jun 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PANAGORA ASSET MANAGEMENT INC holds $63,074,679 across 13 Drug Manufacturers - Specialty & Generic names. XERS ranks #5 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
765,543 | $40,114,453 | |
| 2 | AMRX |
Amneal Pharmaceuticals, Inc.
|
443,647 | $7,679,529 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
216,960 | $5,339,385 | |
| 4 | EBS |
Emergent BioSolutions Inc.
|
329,060 | $2,757,522 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
227,579 | $1,802,425 | |
| 6 | ZTS |
Zoetis Inc.
|
22,499 | $1,616,778 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
2,880 | $1,560,470 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
18,763 | $635,690 |
All Filings in XERS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,802,425 | 227,579 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $607,515 | 104,744 | Shares | Sole | 2026-05-14 | |
| 2025-03-31 | $798,937 | 145,526 | Shares | Sole | 2025-05-15 | |
| 2023-12-31 | $329,747 | 140,318 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $465,372 | 250,200 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $753,512 | 287,600 | Shares | Sole | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||